Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive, Randomized, Non-inferiority Trial to Evaluate the Efficacy of Monoclonal Antibodies in Outpatients With Mild or Moderate COVID-19

NCT05205759 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT05205759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05205759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive, Randomized, Non-inferiority Trial to Evaluate the Efficacy of Monoclonal Antibodies in Outpatients With Mild or Moderate COVID-19
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Phase 3
Overall status
Terminated
Start date
December 9, 2021
Completion date
April 5, 2022
Enrollment
319 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19